ibrutinib,rituximab,bendamustine
roche,janssen,abbvie,biogen,teva pharmaceuticals
['mantle,(-dismantle)', 'ibru', 'shine', 'rituximab', 'lymphoma', 'bendamustine']
live from #eha2022 #noeticinsight brings you the phase iii shine trial results! older patients with untreated mantle-cell lymphoma had markedly longer pfs from ibrutinib + bendamustine-rituximab &amp; rtxmb maintenance, compared to using standard chemoimmunotherapy 